Results 271 to 280 of about 23,888,926 (291)

Physiologically based pharmacokinetic modeling

2007
Deon van der Merwe, Jennifer L. Buur, Jim E. Riviere   +2 more
openaire   +1 more source

Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Support Waivers of In Vivo Clinical Studies: Current Status, Challenges, and Opportunities

Molecular Pharmaceutics, 2021
Jennifer Dressman, Ioannis Loisios-Konstantinidis   +1 more
exaly  

Crosstalk of physiological pH and chemical pKa under the umbrella of physiologically based pharmacokinetic modeling of drug absorption, distribution, metabolism, excretion, and toxicity

Expert Opinion on Drug Metabolism and Toxicology, 2021
Liu Dou, Lu Gaohua, Xiusheng Miao
exaly  

Physiologically-Based Pharmacokinetic (PBPK) Modeling of Buprenorphine in Adults, Children and Preterm Neonates

Pharmaceutics, 2020
Yvonne Kohl, Robert Bals, Dominik Selzer
exaly  

Physiologically Based Pharmacokinetic Models

1993
Jerry N. Blancato, Mahmoud A. Saleh
openaire   +1 more source

Physiologically based pharmacokinetic modeling of polyethylene glycol-coated polyacrylamide nanoparticles in rats

Nanotoxicology, 2014
Olivier Jolliet, Dingsheng Li, Gunnar Johanson   +2 more
exaly  

Physiologically Based Pharmacokinetic Modeling

2004
openaire   +2 more sources

Biological Monitoring: The Role of Toxicokinetics and Physiologically Based Pharmacokinetic Modeling

AIHA Journal, 1999
Howard Mason
exaly  

Challenges Associated With Applying Physiologically Based Pharmacokinetic Modeling for Public Health Decision-Making

Toxicological Sciences, 2018
Jeffrey Fisher, Yu-Mei Tan, Jeremy A Leonard   +2 more
exaly  

Probabilistic risk assessment of gold nanoparticles after intravenous administration by integrating in vitro and in vivo toxicity with physiologically based pharmacokinetic modeling

Nanotoxicology, 2018
Nancy A Monteiro-Riviere, Yi-Hsien Cheng
exaly